Abels B C, Branch R A, Sabra R
Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee.
J Pharmacol Exp Ther. 1993 Mar;264(3):1285-92.
The kidney responds to periods of ischemia with vasoconstriction and a decrease in glomerular filtration rate (GFR) on reperfusion. The mediators of this response have not been fully identified. In this study, we examined the contribution of angiotensin II (AII), thromboxane A2 (TXA2) and the interaction between them to this response. Anesthetized dogs were subjected to 30 min of clamping of both renal arteries. Renal hemodynamics and function were followed from 60 min before and for 105 min after clamping. Dogs were divided into salt-depleted (AII-stimulated) and captopril-treated (AII-inhibited) groups. Each group included dogs that received either the TXA2 synthase inhibitor CGS 13080 or its vehicle (controls) starting 30 min before renal artery clamping and lasting to the end of the experiment. In captopril-treated control dogs, 30 min of ischemia induced a 25% fall in renal blood flow (RBF). GFR initially fell by 75%, but recovered to 64% of base-line value 60 to 90 min after release of the clamp. In captopril-treated dogs, CGS 13080 prevented the fall in RBF, but the GFR response was similar to vehicle-treated dogs. In control dogs, both GFR and RBF responses were enhanced in salt-depleted compared with captopril-treated dogs; the decrease in RBF (44%) was greater, and the recovery in GFR, which fell by 89%, less. In salt-depleted, CGS 13080-treated dogs, the 30% fall in RBF was less than its control, but greater than dogs treated with captopril and CGS 13080. The change in GFR was similar to the other groups.(ABSTRACT TRUNCATED AT 250 WORDS)
肾脏对缺血期的反应是血管收缩,再灌注时肾小球滤过率(GFR)降低。这种反应的介质尚未完全明确。在本研究中,我们检测了血管紧张素II(AII)、血栓素A2(TXA2)及其相互作用对该反应的作用。将麻醉犬的双侧肾动脉夹闭30分钟。在夹闭前60分钟及夹闭后105分钟监测肾脏血流动力学和功能。犬被分为低盐(AII刺激)组和卡托普利治疗(AII抑制)组。每组包括在肾动脉夹闭前30分钟开始至实验结束接受TXA2合酶抑制剂CGS 13080或其溶媒(对照组)的犬。在接受卡托普利治疗的对照犬中,30分钟的缺血导致肾血流量(RBF)下降25%。GFR最初下降75%,但在松开动脉夹60至90分钟后恢复至基线值的64%。在接受卡托普利治疗的犬中,CGS 13080可防止RBF下降,但GFR反应与接受溶媒治疗的犬相似。在对照犬中,与接受卡托普利治疗的犬相比,低盐组的GFR和RBF反应均增强;RBF下降幅度(44%)更大,而下降89%的GFR恢复程度更低。在低盐、接受CGS 13080治疗的犬中,RBF下降30%,低于其对照组,但高于接受卡托普利和CGS 13080治疗的犬。GFR的变化与其他组相似。(摘要截短至250字)